RMD250117C320000
- 1.55
- 0.000.00%
ResMed Newsroom
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Santa Claus Came Without Rallying the Troops | Live Stock
ResMed Gains 37.8% in a Year: What's Driving the Stock?
Resmed Chief Legal Officer Sells Shares
Resmed Inc Adjusts Securities Amid Market Dynamics
ResMed Inc.'s (NYSE:RMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
CICC Initiates ResMed at Outperform With $295 Price Target
Investing in ResMed (NYSE:RMD) Five Years Ago Would Have Delivered You a 56% Gain
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Here's Why You Should Add HAE Stock to Your Portfolio Now
These Stocks Are Moving the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More -- Barrons.com
Top Stock Movers Now: Broadcom, AMD, ResMed, and More
ResMed Shares Are Trading Lower After Rival Eli Lilly Received Approval for Zepbound as an Obstructive Sleep Apnea Treatment for Obese Adults.
These Stocks Are Moving the Most Today: Honda, Qualcomm, Eli Lilly, ResMed, Tesla, Walmart, Rumble, and More -- Barrons.com
Tesla, Eli Lilly, Qualcomm, Honda, Nissan, Nordstrom Among Biggest Movers
Why ResMed (RMD) Is a Top Growth Stock for the Long-Term